Apollon Formulations Kill Triple-Negative Breast Cancer (TNBC) Cells Apollon Formularies plc (AQSE: APOL) ( Apollon or the Company ), a UK based international pharmaceutical company trading on Aquis Stock Exchange, is pleased to announce that its proprietary medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) cells in 3D cell cultures in third party independent laboratory testing. This finding is in addition to the results recently announced on May 18, 2021, that Apollon formulations were successful in killing HER2+ breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ), a BC based international pharmaceutical company trading on the Canadian Securities Exchange.
Find Out How YOU Could Win More With GGPoker s Flip & Go Renewal
pokernews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pokernews.com Daily Mail and Mail on Sunday newspapers.
GGPoker s new Battle Royale Online Poker Events are a Success
worldcasinodirectory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from worldcasinodirectory.com Daily Mail and Mail on Sunday newspapers.
Survey finds Australians don t trust China but want closer ties anyway
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.